Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Firefly Luciferase mRNA as a Delivery Stress Test
2026-08-27
Firefly Luciferase mRNA can do more than report gene expression: it can help separate delivery, stability, and translation effects. This guide connects 5-moUTP modified mRNA design with recent evidence on buffer-controlled LNP stabilization to improve assay interpretation.
-
2',7'-Dichlorofluorescein diacetate: ROS Assay Guide
2026-08-26
This scenario-based guide explains how 2',7'-Dichlorofluorescein diacetate, SKU C3381, supports reproducible intracellular ROS measurement across microscopy, flow cytometry, and plate-based workflows. It covers probe chemistry, preparation, controls, interpretation limits, and practical vendor-selection criteria for cell viability and cytotoxicity studies.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Workflow
2026-08-26
Generate tunable Cy5-labeled RNA probes for spatial transcript detection, Northern blot hybridization, and macrophage-focused studies of TREM2 biology. This workflow shows how to balance fluorescent nucleotide incorporation with probe yield, hybridization quality, and assay-specific controls.
-
Intermedin, NAMPT/PARP1, and VSMC Senescence
2026-08-25
The reference study identifies intermedin (IMD) as a protective regulator of DNA-damage-associated senescent phenotype transition in aortic vascular smooth muscle cells. Its data connect IMD deficiency and angiotensin II stress with increased DNA damage and show that NAMPT-dependent NAD+ production and downstream PARP1 activity are central to the protective response.
-
Sphingosine-1-phosphate: Receptor-Contextual Assays
2026-08-25
Sphingosine-1-phosphate signaling can support vascular biology yet promote neuronal apoptosis in a receptor- and context-dependent manner. This guide shows how to design interpretable S1P experiments by connecting receptor selection, pathway readouts, and fresh-solution handling.
-
Salvianolic Acid B and LH2 in Pulmonary Fibrosis
2026-08-24
The reference study identifies lysyl hydroxylase 2 (LH2/PLOD2) as a collagen cross-linking target through which Salvianolic acid B limits pulmonary fibrosis. By combining LH2 silencing, TGF-β1-stimulated cellular models, and pulmonary fibrosis tissue-level analyses, the work connects extracellular matrix remodeling with EMT, fibroblast-to-myofibroblast transition, and Wnt/β-catenin signaling. These findings support mechanism-guided use of Dan Shen Suan B in pulmonary fibrosis research while leaving questions about direct enzyme inhibition, dosing, and clinical translation unresolved.
-
Podophyllotoxin: Mechanism, HCC Research & Workflows
2026-08-24
Podophyllotoxin is a microtubule-targeting cell cycle arrest agent used in anticancer drug research. This guide separates validated Podophyllotoxin biology from related JXE-23 findings in hepatocellular carcinoma and provides source-linked workflow guidance.
-
Tacrine-Based Hybrids in Alzheimer’s Research
2026-08-23
The 2023 review examines how tacrine has been redesigned as a multi-target scaffold for Alzheimer’s disease drug discovery despite its clinical hepatotoxicity. Its main practical contribution is a comparative view of tacrine hybrids that combine cholinesterase inhibition with activities directed at amyloid aggregation, oxidative stress, metal imbalance, tau pathology, and other disease mechanisms.
-
Cleavage-Resistant TREM2 Restores Macrophage Efferocytosis
2026-08-22
Dong et al. engineered a cleavage-resistant TREM2 receptor that preserves macrophage efferocytosis despite inflammatory ADAM17 activity. Phosphatidylserine-functionalized lipid nanoparticles delivered the receptor’s mRNA in situ, reducing apoptotic-cell accumulation and inflammation in mouse models of MASH and atherosclerosis.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-21
This 2025 review integrates tumor hypoxia, metabolic competition, and immune-cell dysfunction into a dynamic model of immunosuppressive tumor-microenvironment development. Its main practical implication is that therapeutic studies should measure oxygen-sensitive signaling, nutrient use, immune phenotype, and tumor behavior together rather than treating these processes as independent variables.
-
MK0787 vs Cefoperazone: Comparative β-Lactam Activity
2026-08-20
Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with cefoperazone and other newer β-lactams across 470 clinical isolates, emphasizing activity against resistant gram-negative and selected gram-positive organisms. MK0787 showed especially strong bactericidal activity against gram-negative isolates and the best performance against Pseudomonas aeruginosa and Acinetobacter spp., while its relative activity varied by bacterial genus.
-
Cleavage-Resistant TREM2 Restores Efferocytosis
2026-08-20
Dong et al. engineered a synthetic cleavage-resistant TREM2 receptor that preserves macrophage signaling and efferocytosis despite inflammatory ADAM17 activity. In mouse models of metabolic-dysfunction-associated steatohepatitis and atherosclerosis, phosphatidylserine-functionalized lipid nanoparticles delivered CRT mRNA in situ and reduced apoptotic-cell accumulation and inflammation.
-
Dovitinib (TKI-258) Workflows for RTK Cancer Research
2026-08-19
Build more informative RTK assays with Dovitinib by combining phenotypic viability measurements, phospho-signaling readouts, and apoptosis markers. A chamber-specific cardiomyocyte study also offers a practical framework for controlling cellular identity when extending pathway experiments beyond conventional cancer models.
-
PLK1 Control of p31comet in Checkpoint Disassembly
2026-08-19
The reference study identifies Polo-like kinase 1 as a direct regulator of p31comet, showing that PLK1 phosphorylation at S102 suppresses TRIP13-assisted disassembly of mitotic checkpoint complexes. This mechanism explains how active mitotic checkpoints avoid simultaneous MCC assembly and disassembly and provides a biochemical framework for interpreting PLK1 perturbation experiments.
-
Cy5-UTP: Designing RNA Interaction Assays
2026-08-18
Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH and transcript-mapping workflows. This guide connects Cyanine 5-uridine triphosphate labeling with the sequence-dependent RNA interactions revealed in a recent MALAT1 study, translating mechanistic insight into better assay design and interpretation.